nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Edrophonium—BCHE—peripheral nervous system neoplasm	0.0596	1	CrCbGaD
Bretylium—Tenderness—Isotretinoin—peripheral nervous system neoplasm	0.0181	0.0192	CcSEcCtD
Bretylium—Tenderness—Tretinoin—peripheral nervous system neoplasm	0.0181	0.0192	CcSEcCtD
Bretylium—Lightheadedness—Tretinoin—peripheral nervous system neoplasm	0.0141	0.015	CcSEcCtD
Bretylium—Lightheadedness—Isotretinoin—peripheral nervous system neoplasm	0.0141	0.015	CcSEcCtD
Bretylium—Tenderness—Alitretinoin—peripheral nervous system neoplasm	0.0137	0.0146	CcSEcCtD
Bretylium—Nasal congestion—Isotretinoin—peripheral nervous system neoplasm	0.0126	0.0134	CcSEcCtD
Bretylium—Nasal congestion—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0134	CcSEcCtD
Bretylium—Lethargy—Topotecan—peripheral nervous system neoplasm	0.0118	0.0125	CcSEcCtD
Bretylium—Lethargy—Isotretinoin—peripheral nervous system neoplasm	0.0117	0.0124	CcSEcCtD
Bretylium—Lethargy—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0124	CcSEcCtD
Bretylium—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.0117	0.0124	CcSEcCtD
Bretylium—Affect lability—Tretinoin—peripheral nervous system neoplasm	0.0113	0.012	CcSEcCtD
Bretylium—Affect lability—Isotretinoin—peripheral nervous system neoplasm	0.0113	0.012	CcSEcCtD
Bretylium—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.0112	0.0119	CcSEcCtD
Bretylium—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.0112	0.0119	CcSEcCtD
Bretylium—Mood swings—Tretinoin—peripheral nervous system neoplasm	0.0108	0.0115	CcSEcCtD
Bretylium—Mood swings—Isotretinoin—peripheral nervous system neoplasm	0.0108	0.0115	CcSEcCtD
Bretylium—Lightheadedness—Alitretinoin—peripheral nervous system neoplasm	0.0107	0.0114	CcSEcCtD
Bretylium—Hiccups—Cisplatin—peripheral nervous system neoplasm	0.0102	0.0108	CcSEcCtD
Bretylium—Sweating increased—Tretinoin—peripheral nervous system neoplasm	0.00963	0.0102	CcSEcCtD
Bretylium—Sweating increased—Isotretinoin—peripheral nervous system neoplasm	0.00963	0.0102	CcSEcCtD
Bretylium—Lethargy—Dactinomycin—peripheral nervous system neoplasm	0.00954	0.0101	CcSEcCtD
Bretylium—Nasal congestion—Alitretinoin—peripheral nervous system neoplasm	0.00952	0.0101	CcSEcCtD
Bretylium—Lethargy—Alitretinoin—peripheral nervous system neoplasm	0.00885	0.00941	CcSEcCtD
Bretylium—Conjunctivitis—Tretinoin—peripheral nervous system neoplasm	0.00857	0.00911	CcSEcCtD
Bretylium—Conjunctivitis—Isotretinoin—peripheral nervous system neoplasm	0.00857	0.00911	CcSEcCtD
Bretylium—Affect lability—Alitretinoin—peripheral nervous system neoplasm	0.00854	0.00908	CcSEcCtD
Bretylium—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.00847	0.00901	CcSEcCtD
Bretylium—Mood swings—Alitretinoin—peripheral nervous system neoplasm	0.00822	0.00874	CcSEcCtD
Bretylium—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.00811	0.00863	CcSEcCtD
Bretylium—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00735	0.00781	CcSEcCtD
Bretylium—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00735	0.00781	CcSEcCtD
Bretylium—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.0073	0.00776	CcSEcCtD
Bretylium—Flushing—Melphalan—peripheral nervous system neoplasm	0.00725	0.00771	CcSEcCtD
Bretylium—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.00675	0.00718	CcSEcCtD
Bretylium—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.0065	0.00691	CcSEcCtD
Bretylium—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00622	0.00662	CcSEcCtD
Bretylium—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00618	0.00657	CcSEcCtD
Bretylium—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00618	0.00657	CcSEcCtD
Bretylium—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00606	0.00644	CcSEcCtD
Bretylium—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00606	0.00644	CcSEcCtD
Bretylium—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.006	0.00639	CcSEcCtD
Bretylium—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00595	0.00633	CcSEcCtD
Bretylium—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00595	0.00633	CcSEcCtD
Bretylium—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00585	0.00622	CcSEcCtD
Bretylium—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00585	0.00622	CcSEcCtD
Bretylium—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.00579	0.00615	CcSEcCtD
Bretylium—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.0057	0.00606	CcSEcCtD
Bretylium—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00567	0.00603	CcSEcCtD
Bretylium—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00567	0.00603	CcSEcCtD
Bretylium—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00557	0.00592	CcSEcCtD
Bretylium—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00553	0.00589	CcSEcCtD
Bretylium—Shock—Tretinoin—peripheral nervous system neoplasm	0.00553	0.00588	CcSEcCtD
Bretylium—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00553	0.00588	CcSEcCtD
Bretylium—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00548	0.00583	CcSEcCtD
Bretylium—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00544	0.00578	CcSEcCtD
Bretylium—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00544	0.00578	CcSEcCtD
Bretylium—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.00535	0.00569	CcSEcCtD
Bretylium—Hiccups—Epirubicin—peripheral nervous system neoplasm	0.00523	0.00556	CcSEcCtD
Bretylium—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.0052	0.00553	CcSEcCtD
Bretylium—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00505	0.00537	CcSEcCtD
Bretylium—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00501	0.00533	CcSEcCtD
Bretylium—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00501	0.00533	CcSEcCtD
Bretylium—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00495	0.00526	CcSEcCtD
Bretylium—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.00484	0.00514	CcSEcCtD
Bretylium—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00474	0.00504	CcSEcCtD
Bretylium—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00468	0.00498	CcSEcCtD
Bretylium—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00467	0.00497	CcSEcCtD
Bretylium—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00464	0.00493	CcSEcCtD
Bretylium—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00463	0.00493	CcSEcCtD
Bretylium—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00463	0.00493	CcSEcCtD
Bretylium—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.0046	0.00489	CcSEcCtD
Bretylium—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.0046	0.00489	CcSEcCtD
Bretylium—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00459	0.00488	CcSEcCtD
Bretylium—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00452	0.00481	CcSEcCtD
Bretylium—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00451	0.00479	CcSEcCtD
Bretylium—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00448	0.00477	CcSEcCtD
Bretylium—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00448	0.00477	CcSEcCtD
Bretylium—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00445	0.00473	CcSEcCtD
Bretylium—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00445	0.00473	CcSEcCtD
Bretylium—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00445	0.00473	CcSEcCtD
Bretylium—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00445	0.00473	CcSEcCtD
Bretylium—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00443	0.00471	CcSEcCtD
Bretylium—Flushing—Etoposide—peripheral nervous system neoplasm	0.00435	0.00462	CcSEcCtD
Bretylium—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00434	0.00462	CcSEcCtD
Bretylium—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0043	0.00457	CcSEcCtD
Bretylium—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00419	0.00446	CcSEcCtD
Bretylium—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00412	0.00438	CcSEcCtD
Bretylium—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00397	0.00422	CcSEcCtD
Bretylium—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00388	0.00412	CcSEcCtD
Bretylium—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00387	0.00412	CcSEcCtD
Bretylium—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00385	0.00409	CcSEcCtD
Bretylium—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00385	0.00409	CcSEcCtD
Bretylium—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.0038	0.00404	CcSEcCtD
Bretylium—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0038	0.00404	CcSEcCtD
Bretylium—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00379	0.00403	CcSEcCtD
Bretylium—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00378	0.00401	CcSEcCtD
Bretylium—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00376	0.004	CcSEcCtD
Bretylium—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00375	0.00399	CcSEcCtD
Bretylium—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.00373	0.00397	CcSEcCtD
Bretylium—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00372	0.00395	CcSEcCtD
Bretylium—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00372	0.00395	CcSEcCtD
Bretylium—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00366	0.00389	CcSEcCtD
Bretylium—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00363	0.00386	CcSEcCtD
Bretylium—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00363	0.00386	CcSEcCtD
Bretylium—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0036	0.00383	CcSEcCtD
Bretylium—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.00359	0.00382	CcSEcCtD
Bretylium—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00358	0.00381	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00358	0.00381	CcSEcCtD
Bretylium—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00358	0.0038	CcSEcCtD
Bretylium—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00358	0.0038	CcSEcCtD
Bretylium—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00353	0.00375	CcSEcCtD
Bretylium—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00352	0.00374	CcSEcCtD
Bretylium—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00351	0.00374	CcSEcCtD
Bretylium—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00351	0.00373	CcSEcCtD
Bretylium—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00349	0.00371	CcSEcCtD
Bretylium—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00347	0.00369	CcSEcCtD
Bretylium—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00346	0.00367	CcSEcCtD
Bretylium—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00337	0.00358	CcSEcCtD
Bretylium—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00337	0.00358	CcSEcCtD
Bretylium—Nausea—Topotecan—peripheral nervous system neoplasm	0.00337	0.00358	CcSEcCtD
Bretylium—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00336	0.00357	CcSEcCtD
Bretylium—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00335	0.00357	CcSEcCtD
Bretylium—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00334	0.00355	CcSEcCtD
Bretylium—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00334	0.00355	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00333	0.00354	CcSEcCtD
Bretylium—Nausea—Melphalan—peripheral nervous system neoplasm	0.0033	0.00351	CcSEcCtD
Bretylium—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00325	0.00345	CcSEcCtD
Bretylium—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00325	0.00345	CcSEcCtD
Bretylium—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00324	0.00344	CcSEcCtD
Bretylium—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00322	0.00342	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00321	0.00341	CcSEcCtD
Bretylium—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00319	0.0034	CcSEcCtD
Bretylium—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00315	0.00334	CcSEcCtD
Bretylium—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00299	0.00318	CcSEcCtD
Bretylium—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00297	0.00315	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00296	0.00314	CcSEcCtD
Bretylium—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00292	0.00311	CcSEcCtD
Bretylium—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00292	0.0031	CcSEcCtD
Bretylium—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00287	0.00305	CcSEcCtD
Bretylium—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00284	0.00302	CcSEcCtD
Bretylium—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00282	0.003	CcSEcCtD
Bretylium—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00281	0.00299	CcSEcCtD
Bretylium—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00274	0.00292	CcSEcCtD
Bretylium—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00273	0.0029	CcSEcCtD
Bretylium—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00272	0.00289	CcSEcCtD
Bretylium—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00272	0.00289	CcSEcCtD
Bretylium—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00288	CcSEcCtD
Bretylium—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00267	0.00284	CcSEcCtD
Bretylium—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00263	0.0028	CcSEcCtD
Bretylium—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00263	0.0028	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.0028	CcSEcCtD
Bretylium—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00261	0.00278	CcSEcCtD
Bretylium—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00269	CcSEcCtD
Bretylium—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00248	0.00264	CcSEcCtD
Bretylium—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00247	0.00263	CcSEcCtD
Bretylium—Nausea—Vincristine—peripheral nervous system neoplasm	0.00244	0.00259	CcSEcCtD
Bretylium—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00244	0.00259	CcSEcCtD
Bretylium—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00246	CcSEcCtD
Bretylium—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00228	0.00242	CcSEcCtD
Bretylium—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00225	0.0024	CcSEcCtD
Bretylium—Dizziness—Etoposide—peripheral nervous system neoplasm	0.0022	0.00234	CcSEcCtD
Bretylium—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00216	0.00229	CcSEcCtD
Bretylium—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00212	0.00225	CcSEcCtD
Bretylium—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00205	0.00218	CcSEcCtD
Bretylium—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00205	0.00218	CcSEcCtD
Bretylium—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00201	0.00214	CcSEcCtD
Bretylium—Nausea—Etoposide—peripheral nervous system neoplasm	0.00198	0.0021	CcSEcCtD
Bretylium—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00197	0.0021	CcSEcCtD
Bretylium—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00194	0.00206	CcSEcCtD
Bretylium—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.00202	CcSEcCtD
Bretylium—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.00202	CcSEcCtD
Bretylium—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00188	0.002	CcSEcCtD
Bretylium—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00186	0.00198	CcSEcCtD
Bretylium—Shock—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00195	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00194	CcSEcCtD
Bretylium—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.0018	0.00192	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00179	0.00191	CcSEcCtD
Bretylium—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00185	CcSEcCtD
Bretylium—Shock—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.00181	CcSEcCtD
Bretylium—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00177	CcSEcCtD
Bretylium—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00177	CcSEcCtD
Bretylium—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00164	CcSEcCtD
Bretylium—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00163	CcSEcCtD
Bretylium—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00162	CcSEcCtD
Bretylium—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00157	CcSEcCtD
Bretylium—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00157	CcSEcCtD
Bretylium—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00151	CcSEcCtD
Bretylium—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.0015	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00145	CcSEcCtD
Bretylium—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00145	CcSEcCtD
Bretylium—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00136	CcSEcCtD
Bretylium—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00131	CcSEcCtD
Bretylium—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00126	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00126	CcSEcCtD
Bretylium—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00121	CcSEcCtD
Bretylium—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00118	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00117	CcSEcCtD
Bretylium—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00109	CcSEcCtD
